pmid,title,journal,year,drug,disease
40718755,"Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature.",Open access rheumatology : research and reviews,2025,Ruxolitinib,Type 2 Diabetes
34330502,High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients.,Clinical nutrition ESPEN,2021,Ruxolitinib,Type 2 Diabetes
34202668,Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy.,"Pharmaceuticals (Basel, Switzerland)",2021,Ruxolitinib,Type 2 Diabetes
